Consensus Report on Nutrition for Pediatric Patients With Cystic Fibrosis

Borowitz, Drucy; Baker, Robert D.; Stallings, Virginia A.

doi:10.1097/00005176-200209000-00004

Cited by 514 publications

(653 citation statements)

References 87 publications

Supporting

Mentioning

594

Contrasting

Unclassified

Order By: Relevance

“…The enteral forms of vitamin K supplementation are commonly prescribed. These can be in tablet, ampoule (Borowitz 2002;Cystic Fibrosis Trust 2007) or multivitamin preparations (Durie 1994). Vitamin K can also be administered by intramuscular (Shearer 1995) or intravenous injections (Verghese 2003).…”

Section: Description Of the Interventionmentioning

confidence: 99%

“…bone mineral density at the spine (L1-L4) and the total hip (measured by dual energy X-ray absorptiometry (DEXA) scans with z score compared to reference population) (Borowitz 2002) ii. reduction in risk of bone fractures Searching other resources-The following additional resources were used:…”

Section: Bone Formation Outcome Measuresmentioning

confidence: 99%

“…Routine supplementation along with the other fat soluble vitamins is common clinical practice; however, there appears to be very little consensus about the exact dosage that should be prescribed. Until further evidence is available supplementation should continue to follow published ECFS and CFF guidelines (Borowitz 2002;Cystic Fibrosis Trust 2002;Sinaasappel 2002) and be guided by monitoring of the PIVKA or ucOC levels at annual clinical reviews.…”

Section: Authors' Conclusion Implications For Practicementioning

confidence: 99%

“…Further research recommendations based on the EPICOT format (Brown 2006) are presented in the additional tables (Table 3). Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.…”

Section: Implications For Researchmentioning

confidence: 99%

See 3 more Smart Citations

Vitamin K supplementation for cystic fibrosis

Jagannath¹,

Thaker

Chang

et al. 2017

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Section: Description Of the Interventionmentioning

confidence: 99%

Section: Bone Formation Outcome Measuresmentioning

confidence: 99%

Section: Authors' Conclusion Implications For Practicementioning

confidence: 99%

Section: Implications For Researchmentioning

confidence: 99%

See 2 more Smart Citations

Vitamin K supplementation for cystic fibrosis

Jagannath¹,

Thaker

Chang

et al. 2017

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

“…Malnutrition is a substantial, but largely preventable complication for children and adolescents with CF. As malnutrition is recognised as a key factor that adversely affects lung function (Thomson et al, 1995;Steinkamp & Weidemann, 2002) and ultimately survival in those with CF (Corey et al, 1988), nutritional care is considered a major component of CF management (Borowitz et al, 2002). Nutritional status can be assessed by numerous body composition techniques, including skinfolds, bioelectrical impedance and total body potassium, but many of the available techniques have limitations that render them inappropriate for use in children and adolescents with CF (Lands et al, 1993;Stapleton et al, 2001).…”

Section: Introductionmentioning

confidence: 99%

The use of air displacement plethysmography in children and adolescents with cystic fibrosis

et al. 2004

View full text Add to dashboard Cite

Objectives: The purpose of this paper was to evaluate the use of air displacement plethysmography (ADP) in children and adolescents with cystic fibrosis (CF). Specifically, the primary aim of this study was to compare estimates of fat-free mass (FFM) measured from ADP and dual energy X-ray absorptiometry (DEXA) in children and adolescents with CF. The secondary aim was to compare the effect of using predicted thoracic gas volume (V TG ) and measured V TG for the calculation of FFM by ADP in this population. Methods: Cross-sectional FFM measurements were taken using ADP and DEXA in 52 children and adolescents with CF, ranging in age from 6.3 to 16.6 y. Results: Bland-Altman analysis showed that ADP values of FFM were on average 0.59 kg higher than DEXA values (95% limits of agreement ¼ 3.61 to À2.43 kg); however this difference was not significant. There was no significant correlation (r ¼ À0.26, P ¼ 0.07) between the mean FFM and difference in FFM between ADP and DEXA. Using either predicted or measured V TG did not significantly affect FFM estimates in individuals with CF who had normal lung function (bias ¼ À0.3970.86 kg; r ¼ À0.02, P ¼ 0.93). Conclusions: ADP is an appropriate technique for use in children and adolescents with CF.

show abstract